(Circulation. 2001;103:1375.)
© 2001 American Heart Association, Inc.
Editorials |
From the National Heart and Lung Institute Division, Imperial College School of Medicine, London, UK.
Correspondence to Peter H. Sugden, DPhil, NHLI Division (Cardiac Medicine), Imperial College School of Medicine, Dovehouse St, London SW3 6LY, UK. E-mail p.sugden@ic.ac.uk
Key Words: Editorials hypertrophy myocytes signal transduction
The study of ventricular hypertrophy has recently been a fruitful research area. From studies principally in neonatal rat ventricular myocytes in primary culture but now increasingly in transgenic mice, the molecular mechanisms involved in this important pathophysiological adaptation are becoming clearer.1 In culture, cardiomyocyte hypertrophy is characterized by numerous transcriptional and morphological changes, including increased expression of atrial and B-type natriuretic peptides (ANP and BNP, respectively), increased ß-myosin heavy chain (ß-MHC) expression, and increased sarcomere deposition.1 Similar changes are evident in hypertrophied hearts in vivo, where increased sarcomere deposition in particular allows cardiomyocytes to accommodate demands for elevated contractile power.
Wall Strain and Left Ventricular Hypertrophy
In vivo, pathological or experimental left ventricular hemodynamic overload induces patterns of hypertrophy that can be broadly divided into concentric or eccentric. In concentric (pressure-overload) hypertrophy, peak-systolic and end-diastolic pressures are increased, but meridional ventricular wall stress is normal throughout the cardiac cycle, the additional wall stress being counterbalanced by wall thickening in the absence of chamber enlargement. In eccentric (volume-overload) hypertrophy, chamber volume is enlarged, and wall thickness is increased approximately in proportion to the increase in chamber diameter. End-diastolic pressure and wall stress are increased, but peak systolic pressure and wall stress are normal.
The orientation of cardiomyocytes in heart is primarily
circumferential. Thus, cardiomyocytes from pressure- or
volume-overloaded hearts differ in their relative dimensions.
Cross-sectional area is proportionally expanded over length in pressure
overload, whereas length is proportionally increased in volume
overload. Sarcomere deposition parallel to the long axes of cells is
greater in pressure overload than
This article has been cited by other articles:
![]() |
M. A. Frias, S. Somers, C. Gerber-Wicht, L. H. Opie, S. Lecour, and U. Lang The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis Cardiovasc Res, October 1, 2008; 80(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. D. Gonzalez, J. C. Osorio, C. Manlhiot, D. Gruber, S. Homma, and S. Mital Hypertrophy signaling during peripartum cardiac remodeling Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3008 - H3013. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sekiguchi, X. Li, M. Coker, M. Flesch, P. M Barger, N. Sivasubramanian, and D. L Mann Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure Cardiovasc Res, August 15, 2004; 63(3): 433 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Modesti, S. Vanni, I. Bertolozzi, I. Cecioni, C. Lumachi, A. M. Perna, M. Boddi, and G. F. Gensini Different Growth Factor Activation in the Right and Left Ventricles in Experimental Volume Overload Hypertension, January 1, 2004; 43(1): 101 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Baba, J. Stypmann, F. Grabellus, P. Kirchhof, A. Sokoll, M. Schafers, A. Takeda, M. J. Wilhelm, H. H. Scheld, N. Takeda, et al. Dynamic regulation of MEK/Erks and Akt/GSK-3{beta} in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism Cardiovasc Res, August 1, 2003; 59(2): 390 - 399. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |